The Latest Breaking News from HIV

There is no love lost between Anthony Fauci and People for the Ethical Treatment of Animals. PETA repeatedly objected to the director of the National Institute of Allergy and Infectious Diseases’ (NIAID) foolish funding of pointless tests on animals. Those tests include poisoning tests on beagles and decades of vicious…

Freya Leach, 19, a law student at the University of Sydney claims that she has been picked on for her political views with a namesake character used in an exam script

Queen icon Freddie Mercury died following his battle with Aids on November 24, 1991, and released a public statement just 24 hours previously that confirmed he was HIV positive

Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company’s HIV and oncology franchises, which should boost its performance in the upcoming quarters. Given its strong earnings, high profitability, discounted valuation, and attractive dividend, we think…

West Virginia's opioid crisis is transcending partisan politics as city council candidates from three different parties tackle the issue in the capital of Charleston

In his long but fascinating memoir, the self-confessed ‘speechifying’ U2 frontman isn’t shy of exploring the roots of his pomposity, faith and ‘white saviour’ activism

Jermaine Scott, 39, was extradited from Jamaica last night and appeared in court in Warrington this morning

The city council has signed up to meet a new target which will see 95% of people with HIV given sustained antiretroviral therapy by 2025 and to end new transmissions by 2030.

This pandemic can help us prepare for the next one, says Catherine Hankins, co-chair of Canada’s COVID-19 Immunity Task Force

Gareth Thomas visited GSK House in his latest stop on the Myth Bus Tour.

Gilead Sciences reported 79% growth for its cancer drugs, helping beat expectations. On Friday, GILD stock broke out.